Venture Visionary Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$261K Buy
670
+104
+18% +$41.5K 0.01% 597
2026
Q2
$219K Buy
+566
New +$210K 0.01% 652
2026
Q1
– Sell
-656
Closed -$230K – 670
2025
Q4
$230K Sell
656
-1
-0.2% -$338 0.01% 578
2025
Q3
$213K Sell
657
-489
-43% -$152K 0.01% 578
2025
Q2
$446K Buy
1,146
+509
+80% +$205K 0.02% 422
2025
Q1
$277K Sell
637
-17
-3% -$6.82K 0.01% 474
2024
Q4
$241K Buy
654
+1
+0.2% +$418 0.01% 492
2024
Q3
$340K Sell
653
-12
-2% -$6.41K 0.01% 440
2024
Q2
$361K Sell
665
-36
-5% -$19K 0.02% 437
2024
Q1
$364K Sell
701
-24
-3% -$11.9K 0.02% 429
2023
Q4
$342K Buy
725
+21
+3% +$9.71K 0.02% 414
2023
Q3
$307K Sell
704
-48
-6% -$21.8K 0.02% 412
2023
Q2
$334K Buy
752
+19
+3% +$8.77K 0.02% 403
2023
Q1
$337K Sell
733
-197
-21% -$93.8K 0.02% 392
2022
Q4
$477K Sell
930
-119
-11% -$60.4K 0.03% 325
2022
Q3
$476K Buy
1,049
+1
+0.1% +$478 0.04% 311
2022
Q2
$506K Hold
1,048
– – 0.04% 297
2022
Q1
$515K Buy
1,048
+13
+1% +$5.94K 0.03% 319
2021
Q4
$479K Hold
1,035
– – 0.03% 332
2021
Q3
$385K Buy
1,035
+26
+3% +$9.88K 0.03% 360
2021
Q2
$385K Sell
1,009
-37
-4% -$14.1K 0.03% 347
2021
Q1
$375K Sell
1,046
-50
-5% -$16.1K 0.03% 340
2020
Q4
$352K Buy
+1,096
New +$336K 0.04% 292

Other funds holding ELV

Venture Visionary Partners's ELV Position: Q3 2026 in Review

Venture Visionary Partners increased its Elevance Health (ELV) stake by 18% in Q3 2026, buying an estimated $41.5K and bringing the position to 670 shares worth $261K. The position accounts for 0.01% of the portfolio, ranked #597.

Venture Visionary Partners first reported a position in ELV in Q4 2020 and has held it in 23 quarters since. The position peaked at $515K in Q1 2022. 64 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Venture Visionary Partners held 670 shares of Elevance Health worth $261K as of Q3 2026.
  • Venture Visionary Partners bought 104 Elevance Health shares in Q3 2026, an estimated $41.5K.
  • Elevance Health made up 0.01% of Venture Visionary Partners's portfolio in Q3 2026, its #597 holding.
  • Venture Visionary Partners first reported a position in Elevance Health in Q4 2020 and has held it in 23 quarters since.
  • Venture Visionary Partners's Elevance Health position peaked at $515K in Q1 2022.
  • 64 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Venture Visionary Partners's 13F filing for Q3 2026, filed 7 Oct 2026.